These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
535 related items for PubMed ID: 19596182
21. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide. Ferrera F, Hahn BH, Rizzi M, Anderson M, Fitzgerald J, Millo E, Indiveri F, Shi FD, Filaci G, La Cava A. Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718 [Abstract] [Full Text] [Related]
22. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. Chan OT, Madaio MP, Shlomchik MJ. J Immunol; 1999 Oct 01; 163(7):3592-6. PubMed ID: 10490951 [Abstract] [Full Text] [Related]
23. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells. Tago F, Tsukimoto M, Nakatsukasa H, Kojima S. Radiat Res; 2008 Jan 01; 169(1):59-66. PubMed ID: 18159952 [Abstract] [Full Text] [Related]
24. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice]. Kobayashi K, Hamano T, Kakishita E. Ryumachi; 1996 Dec 01; 36(6):844-55. PubMed ID: 9122824 [Abstract] [Full Text] [Related]
28. Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target. Fatenejad S, Brooks W, Schwartz A, Craft J. J Immunol; 1994 Jun 01; 152(11):5523-31. PubMed ID: 7514640 [Abstract] [Full Text] [Related]
30. Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2. Lu LD, Stump KL, Wallace NH, Dobrzanski P, Serdikoff C, Gingrich DE, Dugan BJ, Angeles TS, Albom MS, Mason JL, Ator MA, Dorsey BD, Ruggeri BA, Seavey MM. J Immunol; 2011 Oct 01; 187(7):3840-53. PubMed ID: 21880982 [Abstract] [Full Text] [Related]
31. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice. Hu N, Long H, Zhao M, Yin H, Lu Q. Scand J Rheumatol; 2009 Oct 01; 38(6):464-71. PubMed ID: 19922023 [Abstract] [Full Text] [Related]
32. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. Sadanaga A, Nakashima H, Akahoshi M, Masutani K, Miyake K, Igawa T, Sugiyama N, Niiro H, Harada M. Arthritis Rheum; 2007 May 01; 56(5):1618-28. PubMed ID: 17469144 [Abstract] [Full Text] [Related]
34. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice. Miyazaki T, Ono M, Qu WM, Zhang MC, Mori S, Nakatsuru S, Nakamura Y, Sawasaki T, Endo Y, Nose M. Eur J Immunol; 2005 May 01; 35(5):1510-20. PubMed ID: 15832294 [Abstract] [Full Text] [Related]
35. Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice. Shimizu S, Nakashima H, Masutani K, Inoue Y, Miyake K, Akahoshi M, Tanaka Y, Egashira K, Hirakata H, Otsuka T, Harada M. Rheumatology (Oxford); 2004 Sep 01; 43(9):1121-8. PubMed ID: 15213333 [Abstract] [Full Text] [Related]
36. Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice. Bloom DD, Davignon JL, Cohen PL, Eisenberg RA, Clarke SH. J Immunol; 1993 Feb 15; 150(4):1579-90. PubMed ID: 8432994 [Abstract] [Full Text] [Related]
37. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice. Chuan W, Wu-qing W, Zhu-wen Y, Zuo L. Lupus; 2014 Sep 15; 23(10):994-1005. PubMed ID: 24756437 [Abstract] [Full Text] [Related]